Semaglutide works to lower high blood sugar by increasing the amount of insulin that is released, lowering the amount of glucagon released, and delaying gastric emptying
Liposomal BPC-157 + KPV is an oral, multi-purpose, high absorption peptide formulation of BPC-157, a 15 amino acid derivative of the BPC protein naturally found in the human digestive tract, and KPV, a naturally occurring tripeptide composed of lysine, proline, and valine
Modern healthcare providers and patients are increasingly focused on incorporating GLP-1 therapies to enhance treatment outcomes while satisfying demands for comprehensive diabetes care, including weight management and cardiovascular protection
Because Retatrutide is still under investigation, official dosing guidelines have not been finalized
In clinical trials, people tend to lose more weight on tirzepatide than on semaglutide